Literature DB >> 10982810

A kinetic model for the early steps of RNA synthesis by human RNA polymerase II.

J F Kugel1, J A Goodrich.   

Abstract

Eukaryotic mRNA synthesis is a highly regulated process involving numerous proteins acting in concert with RNA polymerase II to set levels of transcription from individual promoters. The transcription reaction consists of multiple steps beginning with preinitiation complex formation and ending in the production of a full-length primary transcript. We used pre-steady-state approaches to study the steps of human mRNA transcription at the adenovirus major late promoter in a minimal in vitro transcription system. These kinetic studies revealed an early transition in RNA polymerase II transcription, termed escape commitment, that occurs after initiation and prior to promoter escape. Escape commitment is rapid and is characterized by sensitivity to competitor DNA. Upon completion of escape commitment, ternary complexes are resistant to challenge by competitor DNA and slowly proceed forward through promoter escape. Escape commitment is stimulated by transcription factors TFIIE and TFIIH. We measured forward and reverse rate constants for discrete steps in transcription and present a kinetic model for the mechanism of RNA polymerase II transcription that describes five distinct steps (preinitiation complex formation, initiation, escape commitment, promoter escape, and transcript elongation) and clearly shows promoter escape is rate-limiting in this system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10982810     DOI: 10.1074/jbc.M006401200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Translocation after synthesis of a four-nucleotide RNA commits RNA polymerase II to promoter escape.

Authors:  Jennifer F Kugel; James A Goodrich
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

2.  Strong natural pausing by RNA polymerase II within 10 bases of transcription start may result in repeated slippage and reextension of the nascent RNA.

Authors:  Mahadeb Pal; Donal S Luse
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

3.  Promoter clearance by RNA polymerase II is an extended, multistep process strongly affected by sequence.

Authors:  M Pal; D McKean; D S Luse
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

4.  An 8 nt RNA triggers a rate-limiting shift of RNA polymerase II complexes into elongation.

Authors:  Aaron R Hieb; Sean Baran; James A Goodrich; Jennifer F Kugel
Journal:  EMBO J       Date:  2006-06-15       Impact factor: 11.598

5.  TATA-binding protein and transcription factor IIB induce transcript slipping during early transcription by RNA polymerase II.

Authors:  Benjamin Gilman; Linda F Drullinger; Jennifer F Kugel; James A Goodrich
Journal:  J Biol Chem       Date:  2009-02-04       Impact factor: 5.157

6.  A systems view of the protein expression process.

Authors:  Sucheta Gokhale; Dimpal Nyayanit; Chetan Gadgil
Journal:  Syst Synth Biol       Date:  2011-10-19

7.  Initiation complex structure and promoter proofreading.

Authors:  Xin Liu; David A Bushnell; Daniel-Adriano Silva; Xuhui Huang; Roger D Kornberg
Journal:  Science       Date:  2011-07-29       Impact factor: 47.728

8.  The regulatory role for the ERCC3 helicase of general transcription factor TFIIH during promoter escape in transcriptional activation.

Authors:  Aya Fukuda; Yasuhisa Nogi; Koji Hisatake
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

9.  TFIIH operates through an expanded proximal promoter to fine-tune c-myc expression.

Authors:  Achim Weber; Juhong Liu; Irene Collins; David Levens
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

10.  Functional interaction between TFIIB and the Rpb2 subunit of RNA polymerase II: implications for the mechanism of transcription initiation.

Authors:  Bo-Shiun Chen; Michael Hampsey
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.